UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 628

Sortiert nach

Characterization of Differential Tissue Abundance of Major Non-CYP Enzymes in Human

Molecular pharmaceutics, 2020-11, Vol.17 (11), p.4114-4124

2020

Volltextzugriff (PDF)

Regional proteomic quantification of clinically relevant non-cytochrome P450 enzymes along the human small intestine

Drug metabolism and disposition, 2020-07, Vol.48 (7), p.528-536

2020

Volltextzugriff (PDF)

Carboxylesterase catalyzed 18O-labeling of carboxylic acid and its potential application in LC-MS/MS based quantification of drug metabolites

Drug metabolism and pharmacokinetics, 2019-10, Vol.34 (5), p.308-316

2019

Volltextzugriff (PDF)

Characterization of raloxifene glucuronidation in vitro: contribution of intestinal metabolism to presystemic clearance

Drug metabolism and disposition, 2002-06, Vol.30 (6), p.694

2002

Volltextzugriff (PDF)

Investigation of Drug Delivery in Rats via Subcutaneous Injection: Case Study of Pharmacokinetic Modeling of Suspension Formulations

Journal of pharmaceutical sciences, 2019-01, Vol.108 (1), p.109-119

2019

Volltextzugriff (PDF)

Comparison of Tissue Abundance of Non-Cytochrome P450 Drug-Metabolizing Enzymes by Quantitative Proteomics between Humans and Laboratory Animal Species

Drug metabolism and disposition, 2022-03, Vol.50 (3), p.197-203

2022

Volltextzugriff (PDF)

Filling a nick in NIK: Extending the half-life of a NIK inhibitor through structure-based drug design

Bioorganic & medicinal chemistry letters, 2023-06, Vol.89, p.129277-129277, Article 129277

2023

Volltextzugriff (PDF)

Going Beyond Common Drug Metabolizing Enzymes: Case Studies of Biotransformation Involving Aldehyde Oxidase, γ-Glutamyl Transpeptidase, Cathepsin B, Flavin-Containing Monooxygenase, and ADP-Ribosyltransferase

Drug metabolism and disposition, 2016-08, Vol.44 (8), p.1253-1261

2016

Volltextzugriff (PDF)

Rate-Determining and Rate-Limiting Steps in the Clearance and Excretion of a Potent and Selective p21-Activated Kinase Inhibitor: A Case Study of Rapid Hepatic Uptake and Slow Elimination in Rat

Drug metabolism letters, 2016-06, Vol.10 (2), p.91

2016

Volltextzugriff (PDF)

Structure-Guided Design of Group I Selective p21-Activated Kinase Inhibitors

Journal of medicinal chemistry, 2015-06, Vol.58 (12), p.5121-5136

2015

Volltextzugriff (PDF)

Bioactivation of tamoxifen to metabolite E quinone methide: reaction with glutathione and DNA

Drug metabolism and disposition, 2001-06, Vol.29 (6), p.891

2001

Volltextzugriff (PDF)

Structure-Based Discovery of Proline-Derived Arginase Inhibitors with Improved Oral Bioavailability for Immuno-Oncology

ACS medicinal chemistry letters, 2021-09, Vol.12 (9), p.1380-1388

2021

Volltextzugriff (PDF)

Synthesis and Reactivity of a Potential Carcinogenic Metabolite of Tamoxifen: 3,4-Dihydroxytamoxifen-o-quinone

Chemical research in toxicology, 2000-01, Vol.13 (1), p.53-62

2000

Volltextzugriff (PDF)

Mechanism-based inactivation of cytochrome P450 2B6 by a novel terminal acetylene inhibitor

Drug metabolism and disposition, 2003-01, Vol.31 (1), p.28

2003

Volltextzugriff (PDF)

Solving time-dependent CYP3A4 inhibition for a series of indole-phenylacetic acid dual antagonists of the PGD(2) receptors CRTH2 and DP

Bioorganic & medicinal chemistry letters, 2014-07, Vol.24 (13), p.2877-2880

2014

Volltextzugriff (PDF)

Probing Mechanisms of CYP3A Time-Dependent Inhibition Using a Truncated Model System

ACS medicinal chemistry letters, 2015-08, Vol.6 (8), p.925-929

2015

Volltextzugriff (PDF)

Practical permeability-based hepatic clearance classification system (HepCCS) in drug discovery

Future medicinal chemistry, 2014-01, Vol.6 (18), p.1995-2012

2014

Volltextzugriff (PDF)

Elucidation of the mechanism of ribose conjugation in a pyrazole-containing compound in rodent liver

Xenobiotica, 2013-03, Vol.43 (3), p.236-245

2013

Volltextzugriff (PDF)

Novel Mechanism for Dehalogenation and Glutathione Conjugation of Dihalogenated Anilines in Human Liver Microsomes: Evidence for ipso Glutathione Addition

Chemical research in toxicology, 2011-10, Vol.24 (10), p.1668-1677

2011

Volltextzugriff (PDF)

Bioactivation of a novel 2-methylindole-containing dual chemoattractant receptor-homologous molecule expressed on T-helper type-2 cells/D-prostanoid receptor antagonist leads to mechanism-based CYP3A inactivation: glutathione adduct characterization and prediction of in vivo drug-drug interaction

Drug metabolism and disposition, 2010-05, Vol.38 (5), p.841

2010

Volltextzugriff (PDF)

4-Hydroxylated Metabolites of the Antiestrogens Tamoxifen and Toremifene Are Metabolized to Unusually Stable Quinone Methides

Chemical research in toxicology, 2000-01, Vol.13 (1), p.45-52

2000

Volltextzugriff (PDF)

Abstract 297: Innovation in delivering synthetically challenging bicyclic arginase inhibitors to enhance immunotherapy

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.297-297

2021

Volltextzugriff (PDF)

Lifetime and Reactivity of an Ultimate Tamoxifen Carcinogen: The Tamoxifen Carbocation

Journal of the American Chemical Society, 1998-12, Vol.120 (51), p.13513-13514

1998

Volltextzugriff (PDF)

Carboxylesterase catalyzed 18 O-labeling of carboxylic acid and its potential application in LC-MS/MS based quantification of drug metabolites

Drug metabolism and pharmacokinetics, 2019-10, Vol.34 (5), p.308

2019

Volltextzugriff (PDF)

1 – 25 von 628

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(561)
Mit Volltextzugriff
(556)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(478)
Life Sciences & Biomedicine
(317)
Humans
(242)
Male
(133)
Animals
(118)
Female
(118)
Biological And Medical Sciences
(94)
Physical Sciences
(93)
Technology
(85)
Adult
(82)
Medical Sciences
(76)
Middle Aged
(76)
Science & Technology - Other Topics
(46)
Mice
(42)
Computer Science
(41)
Engineering
(41)
Exact Sciences And Technology
(41)
Medicin Och Hälsovetenskap
(41)
Aged
(40)
Adolescent
(39)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Characterization of Differential Tissue Abundance of Major Non-CYP Enzymes in Human

Regional proteomic quantification of clinically relevant non-cytochrome P450 enzymes along the human small intestine

Carboxylesterase catalyzed 18O-labeling of carboxylic acid and its potential application in LC-MS/MS based quantification of drug metabolites

Characterization of raloxifene glucuronidation in vitro: contribution of intestinal metabolism to presystemic clearance

Investigation of Drug Delivery in Rats via Subcutaneous Injection: Case Study of Pharmacokinetic Modeling of Suspension Formulations

Comparison of Tissue Abundance of Non-Cytochrome P450 Drug-Metabolizing Enzymes by Quantitative Proteomics between Humans and Laboratory Animal Species

NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus

Filling a nick in NIK: Extending the half-life of a NIK inhibitor through structure-based drug design

Going Beyond Common Drug Metabolizing Enzymes: Case Studies of Biotransformation Involving Aldehyde Oxidase, γ-Glutamyl Transpeptidase, Cathepsin B, Flavin-Containing Monooxygenase, and ADP-Ribosyltransferase

Rate-Determining and Rate-Limiting Steps in the Clearance and Excretion of a Potent and Selective p21-Activated Kinase Inhibitor: A Case Study of Rapid Hepatic Uptake and Slow Elimination in Rat

Structure-Guided Design of Group I Selective p21-Activated Kinase Inhibitors

Bioactivation of tamoxifen to metabolite E quinone methide: reaction with glutathione and DNA

Structure-Based Discovery of Proline-Derived Arginase Inhibitors with Improved Oral Bioavailability for Immuno-Oncology

Synthesis and Reactivity of a Potential Carcinogenic Metabolite of Tamoxifen: 3,4-Dihydroxytamoxifen-o-quinone

Mechanism-based inactivation of cytochrome P450 2B6 by a novel terminal acetylene inhibitor

Solving time-dependent CYP3A4 inhibition for a series of indole-phenylacetic acid dual antagonists of the PGD(2) receptors CRTH2 and DP

Probing Mechanisms of CYP3A Time-Dependent Inhibition Using a Truncated Model System

Practical permeability-based hepatic clearance classification system (HepCCS) in drug discovery

Elucidation of the mechanism of ribose conjugation in a pyrazole-containing compound in rodent liver

Novel Mechanism for Dehalogenation and Glutathione Conjugation of Dihalogenated Anilines in Human Liver Microsomes: Evidence for ipso Glutathione Addition

Bioactivation of a novel 2-methylindole-containing dual chemoattractant receptor-homologous molecule expressed on T-helper type-2 cells/D-prostanoid receptor antagonist leads to mechanism-based CYP3A inactivation: glutathione adduct characterization and prediction of in vivo drug-drug interaction

4-Hydroxylated Metabolites of the Antiestrogens Tamoxifen and Toremifene Are Metabolized to Unusually Stable Quinone Methides

Abstract 297: Innovation in delivering synthetically challenging bicyclic arginase inhibitors to enhance immunotherapy

Lifetime and Reactivity of an Ultimate Tamoxifen Carcinogen: The Tamoxifen Carbocation

Carboxylesterase catalyzed 18 O-labeling of carboxylic acid and its potential application in LC-MS/MS based quantification of drug metabolites

Suchergebnisse filtern